Selection of control, randomization, blinding, and allocation concealment
Clinical trials looking at which treatment is better must have certain checks in place. Appropriate “control” selection while comparing the investigating agent to the “control group is essential to rule out selection bias. Randomization is another step to minimize variability or “confounders.” By ra...
Main Authors: | Amrita Sil, Piyush Kumar, Rajesh Kumar, Nilay Kanti Das |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Dermatology Online Journal |
Subjects: | |
Online Access: | http://www.idoj.in/article.asp?issn=2229-5178;year=2019;volume=10;issue=5;spage=601;epage=605;aulast=Sil |
Similar Items
-
Quality Assessment of Published Clinical Trials of Mashhad University of Medical Sciences Between 1999 and 2018
by: Z Shateri Amiri, et al.
Published: (2020-08-01) -
Who knew? The misleading specificity of “double-blind” and what to do about it
by: Thomas A. Lang, et al.
Published: (2020-08-01) -
Subversion of allocation concealment in a randomised controlled trial: a historical case study
by: Andrew D. M. Kennedy, et al.
Published: (2017-05-01) -
Allocation concealment appraisal of clinical therapy trials using the extended Composite Quality Score (CQS-2)—An empirically based update
by: Steffen Mickenautsch, et al.
Published: (2023-06-01) -
Concealment in Surat Al-Baqarah: Forms and Consequences
by: Mohammed Abdulaziz Al – Missned
Published: (2014-02-01)